Clearmind Medicine Inc. Common Shares (CMND) — Strategic Asset Allocation Index
Clearmind Medicine Inc. Common Shares (CMND) has a Strategic Asset Allocation Index of 0.3% as of July 2023. Strategic assets (PP&E of $7.30K plus long-term investments of $-) total $7.30K, measured against net assets of $2.13 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Clearmind Medicine Inc. Common Shares Strategic Asset Allocation Index (2018–2021)
This chart shows how Clearmind Medicine Inc. Common Shares's Strategic Asset Allocation Index has evolved across 3 annual periods from 2018 to 2021. As of July 2023, the index stands at 0.3%, representing strategic assets of $7.30K against net assets of $2.13 Million USD. Explore cash efficiency ratio of Clearmind Medicine Inc. Common Shares to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Clearmind Medicine Inc. Common Shares (2018–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Clearmind Medicine Inc. Common Shares from 2018 to 2021, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Clearmind Medicine Inc. Common Shares market cap and net worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 0.5% | $20.58K | $20.58K | $- | $3.87 Million | ▼ -171.3 pp |
| 2019 | 171.8% | $174.59K | $174.59K | $- | $101.63K | ▲ +81.5 pp |
| 2018 | 90.3% | $164.59K | $164.59K | $- | $182.24K | — |